Effects of resveratrol on carbon monoxide-induced cardiotoxicity in rats

Environmental Toxicology and Pharmacology

Volumn 46, Issue , 2016, Pages 110-115

  Hashemzaei, Mahmoud ^a   Barani, Arian Khandan ^a   Iranshahi, Mehrdad ^b   Rezaee, Ramin ^c,d   Tsarouhas, Konstantinos ^e   Tsatsakis, Aristidis Michael ^d   Wilks, Martin F ^f   Tabrizian, Kaveh ^a  

^a ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF CRETE   (Greece)

^e Larisa General Clinic   (Greece)

^f UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Akt; Apoptosis; Carbon monoxide poisoning; Cardiotoxicity; Electrocardiogram; Rat; Resveratrol

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; CASPASE 3; PROTEIN KINASE B; RESVERATROL; CARDIOTONIC AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; HEART PROTECTION; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CARBON MONOXIDE POISONING; CARDIAC MUSCLE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; HEART; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CARBON MONOXIDE; CARBON MONOXIDE POISONING; CARBOXYHEMOGLOBIN; CARDIOTONIC AGENTS; CARDIOTOXICITY; CASPASE 3; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; HEART; MALE; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; STILBENES;

EID: 84978933478     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2016.07.010     Document Type: Article

References (33)

1. Androutsopoulos, V.P., Ruparelia, K.C., Papakyriakou, A., Filippakis, H., Tsatsakis, A.M., Spandidos, D.A., Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency. Eur. J. Med. Chem. 46 (2011), 2586–2595.
2. Cappetta, D., Esposito, G., Piegari, E., Russo, R., Ciuffreda, L.P., Rivellino, A., Berrino, L., Rossi, F., De Angelis, A., Urbanek, K., SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy. Int. J. Cardiol. 205 (2016), 99–110.
3. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., Reed, J.C., Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998), 1318–1321.
4. Chen, W.-P., Su, M.-J., Hung, L.-M., In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur. J. Pharmacol. 554 (2007), 196–204.
5. Chen, C.-J., Yu, W., Fu, Y.-C., Wang, X., Li, J.-L., Wang, W., Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1–FoxO1 pathway. Biochem. Biophys. Res. Commun. 378 (2009), 389–393.
6. Centers for Disease Control and Prevention, 2007. Carbon monoxide–related deaths–United States, 1999–2004. MMWR: Morbidity and mortality weekly report 56, 1309–1312.
7. Ernst, A., Zibrak, J.D., Carbon monoxide poisoning. New Engl. J. Med. 339 (1998), 1603–1608.
8. Fu, D., Regulation of redox signalling and autophagy during cardiovascular diseases-role of resveratrol. Eur. Rev. Med. Pharmacol. Sci. 19 (2015), 1530–1536.
9. Ghorbani, M., Mohammadpour, A.H., Abnous, K., Movassaghi, A.R., Sarshoori, J.R., Shahsavand, S., Hashemzaei, M., Moallem, S.A., G‐CSF administration attenuates brain injury in rats following carbon monoxide poisoning via different mechanisms. Environ. Toxicol., 2015.
10. Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M.K., Gherghiceanu, M., Popescu, L.M., Das, D.K., Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc. Res., 2009, cvp384.
11. Hampson, N.B., Piantadosi, C.A., Thom, S.R., Weaver, L.K., Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. Am. J. Respir. Crit. Care Med. 186 (2012), 1095–1101.
12. Hashemzaei, M., Imen Shahidi, M., Moallem, S.A., Abnous, K., Ghorbani, M., Mohamadpour, A.H., Modulation of JAK2, STAT3 and Akt1 proteins by granulocyte colony stimulating factor following carbon monoxide poisoning in male rat. Drug Chem. Toxicol., 2016, 1–5.
13. Hung, L.-M., Chen, J.-K., Huang, S.-S., Lee, R.-S., Su, M.-J., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res. 47 (2000), 549–555.
14. Iwai-Kanai, E., Hasegawa, K., Araki, M., Kakita, T., Morimoto, T., Sasayama, S., α-and β-adrenergic pathways differentially regulate cell type–specific apoptosis in rat cardiac myocytes. Circulation 100 (1999), 305–311.
15. Lekli, I., Ray, D., Mukherjee, S., Gurusamy, N., Ahsan, M., Juhasz, B., Bak, I., Tosaki, A., Gherghiceanu, M., Popescu, L.M., Co-ordinated autophagy with resveratrol and γ‐tocotrienol confers synergetic cardioprotection. J. Cell. Mol. Med. 14 (2010), 2506–2518.
16. Liao, H.-E., Lai, C.-H., Ho, T.-J., Yeh, Y.-L., Jong, G.-P., Kuo, W.-H., Chung, L.-C., Pai, P., Wen, S.-Y., Huang, C.-Y., Cardio protective effects of lumbrokinase and dilong on second-hand smoke-induced apoptotic signaling in the heart of a rat model. Chin. J. Physiol., 58, 2015.
17. Liman, H., Jankan, C., Shiangsuo, H., RenShen, L., MingJai, S., Visioli, F., Keaney Jr, J., Halliwell, B., Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc. Res., 2000, 549–555.
18. Lin, J.-F., Lin, S.-M., Chih, C.-L., Nien, M.-W., Su, H.-H., Hu, B.-R., Huang, S.-S., Tsai, S.-K., Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci. 83 (2008), 313–317.
19. Lopes Costa, A., Le Bachelier, C., Mathieu, L., Rotig, A., Boneh, A., De Lonlay, P., Tarnopolsky, M.A., Thorburn, D.R., Bastin, J., Djouadi, F., Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. Hum. Mol. Genet. 23 (2014), 2106–2119.
20. Louzada, R.A., Oliveira, P.F., Cavalcanti-de-Albuquerque, J.P.A., Cunha-Carvalho, L., Baldanza, M.R., Kasai-Brunswick, T.H., Goldenberg, R.C., Campos-de-Carvalho, A.C., Werneck-de-Castro, J.P., Granulocyte-colony stimulating factor treatment of chronic myocardial infarction. Cardiovasc. Drugs Ther. 24 (2010), 121–130.
21. Moallem, S.A., Mohamadpour, A.H., Abnous, K., Sankian, M., Sadeghnia, H.R., Tsatsakis, A., Shahsavand, S., Erythropoietin in the treatment of carbon monoxide neurotoxicity in rat. Food Chem. Toxicol. 86 (2015), 56–64.
22. Mohamadpour, A.H., Moallem, S.A., Hashemzaei, M., Abnous, K., Tabatabaee Yazdi, S.A., Imenshahidi, M., Effects of granulocyte colony-stimulating factor on electrocardiogram changes after carbon monoxide poisoning in rats. Drug Chem. Toxicol. 35 (2012), 353–360.
23. Nitulescu, G.M., Margina, D., Juzenas, P., Peng, Q., Olaru, O.T., Saloustros, E., Fenga, C., Spandidos, D.Α., Libra, M., Tsatsakis, A.M., Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use (Review). Int. J. Oncol. 48 (2016), 869–885.
24. Pangeni, R., Sahni, J.K., Ali, J., Sharma, S., Baboota, S., Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin. Drug Deliv. 11 (2014), 1285–1298.
25. Prockop, L.D., Chichkova, R.I., Carbon monoxide intoxication: an updated review. J. Neurol. Sci. 262 (2007), 122–130.
26. Rezaee, M.A., Mohammadpour, A.H., Imenshahidi, M., Mahmoudi, M., Sankian, M., Tsarouhas, K., Tsakalof, A., Tsatsakis, A.M., Moallem, S.A., Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide. Life Sci. 148 (2016), 118–124.
27. Rodkey, F., Hill, T., Pitts, L., Robertson, R., Spectrophotometric measurement of carboxyhemoglobin and methemoglobin in blood. Clin. Chem. 25 (1979), 1388–1393.
28. Satran, D., Henry, C.R., Adkinson, C., Nicholson, C.I., Bracha, Y., Henry, T.D., Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J. Am. Coll. Cardiol. 45 (2005), 1513–1516.
29. Shahsavand, S., Mohammadpour, A.H., Rezaee, R., Behravan, E., Sakhtianchi, R., Moallem, S.A., Effect of erythropoietin on serum brain-derived biomarkers after carbon monoxide poisoning in rats. Iran. J. Basic Med. Sci. 15 (2012), 752–758.
30. Sheikhazadi, A., Anary, S.H.S., Ghadyani, M.H., Nonfire carbon monoxide-related deaths: a survey in Tehran, Iran (2002–2006). Am. J. Forenic Med. Pathol. 31 (2010), 359–363.
31. Wang, Z., Gu, J., Wang, X., Xie, K., Luan, Q., Wan, N., Zhang, Q., Jiang, H., Liu, D., Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: the HPA axis, BDNF expression and phosphorylation of ERK. Pharmacol. Biochem. Behav. 112 (2013), 104–110.
32. Yamaguchi, A., Tamatani, M., Matsuzaki, H., Namikawa, K., Kiyama, H., Vitek, M.P., Mitsuda, N., Tohyama, M., Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276 (2001), 5256–5264.
33. Yamaguchi, H., Wang, H.-G., The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20 (2001), 7779–7786.